{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T11:12:41Z","timestamp":1792494761427,"version":"4.5.0"},"reference-count":107,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,7,6]],"date-time":"2022-07-06T00:00:00Z","timestamp":1657065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,7,6]],"date-time":"2022-07-06T00:00:00Z","timestamp":1657065600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Commun Biol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>We are amid the historic coronavirus infectious disease 2019 (COVID-19) pandemic. Imbalances in the accessibility of vaccines, medicines, and diagnostics among countries, regions, and populations, and those in war crises, have been problematic. Nanobodies are small, stable, customizable, and inexpensive to produce. Herein, we present a panel of nanobodies that can detect the spike proteins of five SARS-CoV-2 variants of concern (VOCs) including Omicron. Here we show via ELISA, lateral flow, kinetic, flow cytometric, microscopy, and Western blotting assays that our nanobodies can quantify the spike variants. This panel of nanobodies broadly neutralizes viral infection caused by pseudotyped and authentic SARS-CoV-2 VOCs. Structural analyses show that the P86 clone targets epitopes that are conserved yet unclassified on the receptor-binding domain (RBD) and contacts the N-terminal domain (NTD). Human antibodies rarely access both regions; consequently, the clone buries hidden crevasses of SARS-CoV-2 spike proteins that go undetected by conventional antibodies.<\/jats:p>","DOI":"10.1038\/s42003-022-03630-3","type":"journal-article","created":{"date-parts":[[2022,7,6]],"date-time":"2022-07-06T05:03:33Z","timestamp":1657083813000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":46,"title":["A panel of nanobodies recognizing conserved hidden clefts of all SARS-CoV-2 spike variants including Omicron"],"prefix":"10.1038","volume":"5","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1514-1071","authenticated-orcid":false,"given":"Ryota","family":"Maeda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1273-3917","authenticated-orcid":false,"given":"Junso","family":"Fujita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1212-7212","authenticated-orcid":false,"given":"Yoshinobu","family":"Konishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1046-8286","authenticated-orcid":false,"given":"Yasuhiro","family":"Kazuma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Yamazaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Itsuki","family":"Anzai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tokiko","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keishi","family":"Yamaguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1803-4036","authenticated-orcid":false,"given":"Kazuki","family":"Kasai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kayoko","family":"Nagata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutaro","family":"Yamaoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kei","family":"Miyakawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihide","family":"Ryo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7469-1276","authenticated-orcid":false,"given":"Kotaro","family":"Shirakawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4431-1380","authenticated-orcid":false,"given":"Kei","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9512-7087","authenticated-orcid":false,"given":"Fumiaki","family":"Makino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9091-8285","authenticated-orcid":false,"given":"Yoshiharu","family":"Matsuura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsuyoshi","family":"Inoue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8673-8983","authenticated-orcid":false,"given":"Akihiro","family":"Imura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2911-5875","authenticated-orcid":false,"given":"Keiichi","family":"Namba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7678-4284","authenticated-orcid":false,"given":"Akifumi","family":"Takaori-Kondo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,7,6]]},"reference":[{"key":"3630_CR1","doi-asserted-by":"publisher","first-page":"3936","DOI":"10.1016\/j.cell.2021.06.005","volume":"184","author":"F Amanat","year":"2021","unstructured":"Amanat, F. et al. SARS-CoV-2 mRNA vaccination induces functionally diverse antibodies to NTD, RBD, and S2. Cell 184, 3936\u20133948 e3910 (2021).","journal-title":"Cell"},{"key":"3630_CR2","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1038\/s41586-021-03696-9","volume":"595","author":"Z Wang","year":"2021","unstructured":"Wang, Z. et al. Naturally enhanced neutralizing breadth against SARS-CoV-2 one year after infection. Nature 595, 426\u2013431 (2021).","journal-title":"Nature"},{"key":"3630_CR3","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1038\/s41586-021-03412-7","volume":"593","author":"DA Collier","year":"2021","unstructured":"Collier, D. A. et al. Sensitivity of SARS-CoV-2 B.1.1.7 to mRNA vaccine-elicited antibodies. Nature 593, 136\u2013141 (2021).","journal-title":"Nature"},{"key":"3630_CR4","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1038\/s41594-020-0469-6","volume":"27","author":"J Huo","year":"2020","unstructured":"Huo, J. et al. Neutralizing nanobodies bind SARS-CoV-2 spike RBD and block interaction with ACE2. Nat. Struct. Mol. Biol. 27, 846\u2013854 (2020).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"3630_CR5","doi-asserted-by":"publisher","DOI":"10.1007\/s13205-021-02647-5","volume":"11","author":"S Bessalah","year":"2021","unstructured":"Bessalah, S. et al. Perspective on therapeutic and diagnostic potential of camel nanobodies for coronavirus disease-19 (COVID-19). 3 Biotech 11, 89 (2021).","journal-title":"3 Biotech"},{"key":"3630_CR6","doi-asserted-by":"publisher","DOI":"10.1126\/science.abe6230","volume":"371","author":"PA Koenig","year":"2021","unstructured":"Koenig, P. A. et al. Structure-guided multivalent nanobodies block SARS-CoV-2 infection and suppress mutational escape. Science 371, eabe6230 (2021).","journal-title":"Science"},{"key":"3630_CR7","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1093\/bioinformatics\/btaa739","volume":"37","author":"MIJ Raybould","year":"2021","unstructured":"Raybould, M. I. J., Kovaltsuk, A., Marks, C. & Deane, C. M. CoV-AbDab: the coronavirus antibody database. Bioinformatics 37, 734\u2013735 (2021).","journal-title":"Bioinformatics"},{"key":"3630_CR8","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1038\/s41586-021-03720-y","volume":"596","author":"RE Chen","year":"2021","unstructured":"Chen, R. E. et al. In vivo monoclonal antibody efficacy against SARS-CoV-2 variant strains. Nature 596, 103\u2013108 (2021).","journal-title":"Nature"},{"key":"3630_CR9","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1038\/s41586-021-04005-0","volume":"600","author":"F Schmidt","year":"2021","unstructured":"Schmidt, F. et al. High genetic barrier to SARS-CoV-2 polyclonal neutralizing antibody escape. Nature 600, 512\u2013516 (2021).","journal-title":"Nature"},{"key":"3630_CR10","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1038\/s41586-021-03398-2","volume":"593","author":"P Wang","year":"2021","unstructured":"Wang, P. et al. Antibody resistance of SARS-CoV-2 variants B.1.351 and B.1.1.7. Nature 593, 130\u2013135 (2021).","journal-title":"Nature"},{"key":"3630_CR11","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1038\/363446a0","volume":"363","author":"C Hamers-Casterman","year":"1993","unstructured":"Hamers-Casterman, C. et al. Naturally occurring antibodies devoid of light chains. Nature 363, 446\u2013448 (1993).","journal-title":"Nature"},{"key":"3630_CR12","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1038\/nprot.2014.039","volume":"9","author":"E Pardon","year":"2014","unstructured":"Pardon, E. et al. A general protocol for the generation of Nanobodies for structural biology. Nat. Protoc. 9, 674\u2013693 (2014).","journal-title":"Nat. Protoc."},{"key":"3630_CR13","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1126\/science.abg2294","volume":"371","author":"X Saelens","year":"2021","unstructured":"Saelens, X. & Schepens, B. Single-domain antibodies make a difference. Science 371, 681\u2013682 (2021).","journal-title":"Science"},{"key":"3630_CR14","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s40259-019-00392-z","volume":"34","author":"I Jovcevska","year":"2020","unstructured":"Jovcevska, I. & Muyldermans, S. The therapeutic potential of nanobodies. BioDrugs 34, 11\u201326 (2020).","journal-title":"BioDrugs"},{"key":"3630_CR15","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.tim.2020.12.006","volume":"29","author":"TF Czajka","year":"2021","unstructured":"Czajka, T. F., Vance, D. J. & Mantis, N. J. Slaying SARS-CoV-2 one (single-domain) antibody at a time. Trends Microbiol. 29, 195\u2013203 (2021).","journal-title":"Trends Microbiol."},{"key":"3630_CR16","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1016\/j.cell.2018.12.028","volume":"176","author":"AC Walls","year":"2019","unstructured":"Walls, A. C. et al. Unexpected receptor functional mimicry elucidates activation of coronavirus fusion. Cell 176, 1026\u20131039 e1015 (2019).","journal-title":"Cell"},{"key":"3630_CR17","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.cell.2020.02.058","volume":"181","author":"AC Walls","year":"2020","unstructured":"Walls, A. C. et al. Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein. Cell 181, 281\u2013292 e286 (2020).","journal-title":"Cell"},{"key":"3630_CR18","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","volume":"181","author":"M Hoffmann","year":"2020","unstructured":"Hoffmann, M. et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell 181, 271\u2013280 e278 (2020).","journal-title":"Cell"},{"key":"3630_CR19","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/j.cell.2020.09.032","volume":"183","author":"L Yurkovetskiy","year":"2020","unstructured":"Yurkovetskiy, L. et al. Structural and functional analysis of the D614G SARS-CoV-2 spike protein variant. Cell 183, 739\u2013751 e738 (2020).","journal-title":"Cell"},{"key":"3630_CR20","doi-asserted-by":"publisher","first-page":"1666","DOI":"10.1073\/pnas.0913986107","volume":"107","author":"K Tomiyama","year":"2010","unstructured":"Tomiyama, K. et al. Relevant use of Klotho in FGF19 subfamily signaling system in vivo. Proc. Natl Acad. Sci. USA 107, 1666\u20131671 (2010).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"3630_CR21","doi-asserted-by":"publisher","first-page":"4380","DOI":"10.1016\/j.cell.2021.06.008","volume":"184","author":"H Zhou","year":"2021","unstructured":"Zhou, H. et al. Identification of novel bat coronaviruses sheds light on the evolutionary origins of SARS-CoV-2 and related viruses. Cell 184, 4380\u20134391 e4314 (2021).","journal-title":"Cell"},{"key":"3630_CR22","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1038\/nature09648","volume":"469","author":"SG Rasmussen","year":"2011","unstructured":"Rasmussen, S. G. et al. Structure of a nanobody-stabilized active state of the beta(2) adrenoceptor. Nature 469, 175\u2013180 (2011).","journal-title":"Nature"},{"key":"3630_CR23","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1016\/j.cell.2020.09.033","volume":"183","author":"TM Clausen","year":"2020","unstructured":"Clausen, T. M. et al. SARS-CoV-2 infection depends on cellular heparan sulfate and ACE2. Cell 183, 1043\u20131057 e1015 (2020).","journal-title":"Cell"},{"key":"3630_CR24","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-24507-9","volume":"12","author":"A Kawamoto","year":"2021","unstructured":"Kawamoto, A. et al. Native flagellar MS ring is formed by 34 subunits with 23-fold and 11-fold subsymmetries. Nat. Commun. 12, 4223 (2021).","journal-title":"Nat. Commun."},{"key":"3630_CR25","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1038\/s41577-020-00480-0","volume":"21","author":"L Dai","year":"2021","unstructured":"Dai, L. & Gao, G. F. Viral targets for vaccines against COVID-19. Nat. Rev. Immunol. 21, 73\u201382 (2021).","journal-title":"Nat. Rev. Immunol."},{"key":"3630_CR26","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1038\/nsmb.1497","volume":"15","author":"K Shirakawa","year":"2008","unstructured":"Shirakawa, K. et al. Phosphorylation of APOBEC3G by protein kinase A regulates its interaction with HIV-1 Vif. Nat. Struct. Mol. Biol. 15, 1184\u20131191 (2008).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"3630_CR27","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/s41594-019-0233-y","volume":"26","author":"MA Tortorici","year":"2019","unstructured":"Tortorici, M. A. et al. Structural basis for human coronavirus attachment to sialic acid receptors. Nat. Struct. Mol. Biol. 26, 481\u2013489 (2019).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"3630_CR28","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1038\/s41586-021-03676-z","volume":"595","author":"J Xu","year":"2021","unstructured":"Xu, J. et al. Nanobodies from camelid mice and llamas neutralize SARS-CoV-2 variants. Nature 595, 278\u2013282 (2021).","journal-title":"Nature"},{"key":"3630_CR29","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1038\/s41586-021-03944-y","volume":"599","author":"P Mlcochova","year":"2021","unstructured":"Mlcochova, P. et al. SARS-CoV-2 B.1.617.2 Delta variant replication and immune evasion. Nature 599, 114\u2013119 (2021).","journal-title":"Nature"},{"key":"3630_CR30","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1038\/s41586-021-03402-9","volume":"592","author":"H Tegally","year":"2021","unstructured":"Tegally, H. et al. Detection of a SARS-CoV-2 variant of concern in South Africa. Nature 592, 438\u2013443 (2021).","journal-title":"Nature"},{"key":"3630_CR31","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1038\/s41586-022-04411-y","volume":"603","author":"R Viana","year":"2022","unstructured":"Viana, R. et al. Rapid epidemic expansion of the SARS-CoV-2 Omicron variant in southern Africa. Nature 603, 679\u2013686 (2022).","journal-title":"Nature"},{"key":"3630_CR32","doi-asserted-by":"publisher","first-page":"3426","DOI":"10.1016\/j.cell.2021.04.025","volume":"184","author":"X Deng","year":"2021","unstructured":"Deng, X. et al. Transmission, infectivity, and neutralization of a spike L452R SARS-CoV-2 variant. Cell 184, 3426\u20133437 e3428 (2021).","journal-title":"Cell"},{"key":"3630_CR33","doi-asserted-by":"publisher","first-page":"2939","DOI":"10.1016\/j.cell.2021.03.055","volume":"184","author":"W Dejnirattisai","year":"2021","unstructured":"Dejnirattisai, W. et al. Antibody evasion by the P.1 strain of SARS-CoV-2. Cell 184, 2939\u20132954 e2939 (2021).","journal-title":"Cell"},{"key":"3630_CR34","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1038\/s41586-021-03471-w","volume":"593","author":"S Cele","year":"2021","unstructured":"Cele, S. et al. Escape of SARS-CoV-2 501Y.V2 from neutralization by convalescent plasma. Nature 593, 142\u2013146 (2021).","journal-title":"Nature"},{"key":"3630_CR35","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1016\/j.cell.2020.04.031","volume":"181","author":"D Wrapp","year":"2020","unstructured":"Wrapp, D. et al. Structural basis for potent neutralization of betacoronaviruses by single-domain camelid antibodies. Cell 181, 1004\u20131015 e1015 (2020).","journal-title":"Cell"},{"key":"3630_CR36","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1126\/science.abe3255","volume":"370","author":"M Schoof","year":"2020","unstructured":"Schoof, M. et al. An ultrapotent synthetic nanobody neutralizes SARS-CoV-2 by stabilizing inactive Spike. Science 370, 1473\u20131479 (2020).","journal-title":"Science"},{"key":"3630_CR37","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-18174-5","volume":"11","author":"L Hanke","year":"2020","unstructured":"Hanke, L. et al. An alpaca nanobody neutralizes SARS-CoV-2 by blocking receptor interaction. Nat. Commun. 11, 4420 (2020).","journal-title":"Nat. Commun."},{"key":"3630_CR38","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.1126\/science.1135901","volume":"316","author":"A Imura","year":"2007","unstructured":"Imura, A. et al. alpha-Klotho as a regulator of calcium homeostasis. Science 316, 1615\u20131618 (2007).","journal-title":"Science"},{"key":"3630_CR39","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-014-0352-5","volume":"12","author":"M Zhu","year":"2014","unstructured":"Zhu, M., Gong, X., Hu, Y., Ou, W. & Wan, Y. Streptavidin-biotin-based directional double Nanobody sandwich ELISA for clinical rapid and sensitive detection of influenza H5N1. J. Transl. Med. 12, 352 (2014).","journal-title":"J. Transl. Med."},{"key":"3630_CR40","doi-asserted-by":"publisher","first-page":"eabi5273","DOI":"10.1126\/science.abi5273","volume":"373","author":"TC Jones","year":"2021","unstructured":"Jones, T. C. et al. Estimating infectiousness throughout SARS-CoV-2 infection course. Science 373, eabi5273 (2021).","journal-title":"Science"},{"key":"3630_CR41","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1038\/s41591-021-01318-5","volume":"27","author":"D Planas","year":"2021","unstructured":"Planas, D. et al. Sensitivity of infectious SARS-CoV-2 B.1.1.7 and B.1.351 variants to neutralizing antibodies. Nat. Med. 27, 917\u2013924 (2021).","journal-title":"Nat. Med."},{"key":"3630_CR42","doi-asserted-by":"publisher","first-page":"2332","DOI":"10.1016\/j.cell.2021.03.028","volume":"184","author":"M McCallum","year":"2021","unstructured":"McCallum, M. et al. N-terminal domain antigenic mapping reveals a site of vulnerability for SARS-CoV-2. Cell 184, 2332\u20132347 e2316 (2021).","journal-title":"Cell"},{"key":"3630_CR43","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1016\/j.cell.2021.01.037","volume":"184","author":"EC Thomson","year":"2021","unstructured":"Thomson, E. C. et al. Circulating SARS-CoV-2 spike N439K variants maintain fitness while evading antibody-mediated immunity. Cell 184, 1171\u20131187 e1120 (2021).","journal-title":"Cell"},{"key":"3630_CR44","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1016\/j.chom.2021.02.020","volume":"29","author":"JA Plante","year":"2021","unstructured":"Plante, J. A. et al. The variant gambit: COVID-19\u2019s next move. Cell Host Microbe 29, 508\u2013515 (2021).","journal-title":"Cell Host Microbe"},{"key":"3630_CR45","unstructured":"WHO. Tracking SARS-CoV-2 Variants. https:\/\/www.who.int\/en\/activities\/tracking-SARS-CoV-2-variants (2022)."},{"key":"3630_CR46","unstructured":"WHO. COVID-19 Weekly Epidemiological Update Vol. 82. https:\/\/www.who.int\/publications\/m\/item\/weekly-epidemiological-update-on-covid-19-22-march-2022# (2022)."},{"key":"3630_CR47","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1038\/s41586-020-2852-1","volume":"588","author":"CO Barnes","year":"2020","unstructured":"Barnes, C. O. et al. SARS-CoV-2 neutralizing antibody structures inform therapeutic strategies. Nature 588, 682\u2013687 (2020).","journal-title":"Nature"},{"key":"3630_CR48","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1016\/j.cell.2020.09.037","volume":"183","author":"L Piccoli","year":"2020","unstructured":"Piccoli, L. et al. Mapping neutralizing and immunodominant sites on the SARS-CoV-2 spike receptor-binding domain by structure-guided high-resolution serology. Cell 183, 1024\u20131042 e1021 (2020).","journal-title":"Cell"},{"key":"3630_CR49","doi-asserted-by":"publisher","first-page":"3086","DOI":"10.1016\/j.cell.2021.05.005","volume":"184","author":"D Corti","year":"2021","unstructured":"Corti, D., Purcell, L. A., Snell, G. & Veesler, D. Tackling COVID-19 with neutralizing monoclonal antibodies. Cell 184, 3086\u20133108 (2021).","journal-title":"Cell"},{"key":"3630_CR50","doi-asserted-by":"publisher","first-page":"4203","DOI":"10.1016\/j.cell.2021.06.021","volume":"184","author":"D Li","year":"2021","unstructured":"Li, D. et al. In vitro and in vivo functions of SARS-CoV-2 infection-enhancing and neutralizing antibodies. Cell 184, 4203\u20134219 e4232 (2021).","journal-title":"Cell"},{"key":"3630_CR51","doi-asserted-by":"crossref","unstructured":"Guttler, T. et al. Neutralization of SARS-CoV-2 by highly potent, hyperthermostable, and mutation-tolerant nanobodies. EMBO J. 40, e107985 (2021).","DOI":"10.15252\/embj.2021107985"},{"key":"3630_CR52","doi-asserted-by":"publisher","first-page":"1808","DOI":"10.1002\/jmv.27601","volume":"94","author":"PA Desingu","year":"2022","unstructured":"Desingu, P. A., Nagarajan, K. & Dhama, K. Emergence of Omicron third lineage BA.3 and its importance. J. Med Virol. 94, 1808\u20131810 (2022).","journal-title":"J. Med Virol."},{"key":"3630_CR53","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1038\/s41586-021-04388-0","volume":"602","author":"L Liu","year":"2022","unstructured":"Liu, L. et al. Striking antibody evasion manifested by the Omicron variant of SARS-CoV-2. Nature 602, 676\u2013681 (2022).","journal-title":"Nature"},{"key":"3630_CR54","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1126\/science.abn7760","volume":"375","author":"D Mannar","year":"2022","unstructured":"Mannar, D. et al. SARS-CoV-2 Omicron variant: antibody evasion and cryo-EM structure of spike protein-ACE2 complex. Science 375, 760\u2013764 (2022).","journal-title":"Science"},{"key":"3630_CR55","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1126\/science.abn8652","volume":"375","author":"M McCallum","year":"2022","unstructured":"McCallum, M. et al. Structural basis of SARS-CoV-2 Omicron immune evasion and receptor engagement. Science 375, 864\u2013868 (2022).","journal-title":"Science"},{"key":"3630_CR56","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1038\/s41586-021-04389-z","volume":"602","author":"D Planas","year":"2022","unstructured":"Planas, D. et al. Considerable escape of SARS-CoV-2 Omicron to antibody neutralization. Nature 602, 671\u2013675 (2022).","journal-title":"Nature"},{"key":"3630_CR57","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1038\/s41586-021-04386-2","volume":"602","author":"E Cameroni","year":"2022","unstructured":"Cameroni, E. et al. Broadly neutralizing antibodies overcome SARS-CoV-2 Omicron antigenic shift. Nature 602, 664\u2013670 (2022).","journal-title":"Nature"},{"key":"3630_CR58","doi-asserted-by":"crossref","unstructured":"Iketani, S. et al. Antibody evasion properties of SARS-CoV-2 Omicron sublineages. Nature 604, 553\u2013556 (2022).","DOI":"10.1038\/s41586-022-04594-4"},{"key":"3630_CR59","doi-asserted-by":"crossref","unstructured":"Yamasoba, D. et al. Virological characteristics of SARS-CoV-2 BA.2 variant. Cell 185, 2103\u20132115.e19 (2022).","DOI":"10.1016\/j.cell.2022.04.035"},{"key":"3630_CR60","doi-asserted-by":"publisher","first-page":"100527","DOI":"10.1016\/j.xcrm.2022.100527","volume":"3","author":"NL Miller","year":"2022","unstructured":"Miller, N. L., Clark, T., Raman, R. & Sasisekharan, R. Insights on the mutational landscape of the SARS-CoV-2 Omicron variant receptor-binding domain. Cell Rep. Med. 3, 100527 (2022).","journal-title":"Cell Rep. Med."},{"key":"3630_CR61","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1016\/j.jmb.2007.05.022","volume":"372","author":"E Krissinel","year":"2007","unstructured":"Krissinel, E. & Henrick, K. Inference of macromolecular assemblies from crystalline state. J. Mol. Biol. 372, 774\u2013797 (2007).","journal-title":"J. Mol. Biol."},{"key":"3630_CR62","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1016\/j.cell.2022.01.019","volume":"185","author":"Z Cui","year":"2022","unstructured":"Cui, Z. et al. Structural and functional characterizations of infectivity and immune evasion of SARS-CoV-2 Omicron. Cell 185, 860\u2013871 e813 (2022).","journal-title":"Cell"},{"key":"3630_CR63","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1126\/science.abn8863","volume":"375","author":"W Yin","year":"2022","unstructured":"Yin, W. et al. Structures of the Omicron spike trimer with ACE2 and an anti-Omicron antibody. Science 375, 1048\u20131053 (2022).","journal-title":"Science"},{"key":"3630_CR64","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1038\/s41586-022-04442-5","volume":"603","author":"H Shuai","year":"2022","unstructured":"Shuai, H. et al. Attenuated replication and pathogenicity of SARS-CoV-2 B.1.1.529 Omicron. Nature 603, 693\u2013699 (2022).","journal-title":"Nature"},{"key":"3630_CR65","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.cell.2021.12.032","volume":"185","author":"M Hoffmann","year":"2022","unstructured":"Hoffmann, M. et al. The Omicron variant is highly resistant against antibody-mediated neutralization: Implications for control of the COVID-19 pandemic. Cell 185, 447\u2013456 e411 (2022).","journal-title":"Cell"},{"key":"3630_CR66","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1038\/s41586-022-04474-x","volume":"603","author":"B Meng","year":"2022","unstructured":"Meng, B. et al. Altered TMPRSS2 usage by SARS-CoV-2 Omicron impacts infectivity and fusogenicity. Nature 603, 706\u2013714 (2022).","journal-title":"Nature"},{"key":"3630_CR67","doi-asserted-by":"crossref","unstructured":"Gobeil, S. M. et al. Effect of natural mutations of SARS-CoV-2 on spike structure, conformation, and antigenicity. Science 373, eabi6226 (2021).","DOI":"10.1126\/science.abi6226"},{"key":"3630_CR68","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.cell.2020.05.025","volume":"182","author":"Y Cao","year":"2020","unstructured":"Cao, Y. et al. Potent neutralizing antibodies against SARS-CoV-2 identified by high-throughput single-cell sequencing of convalescent patients\u2019 B cells. Cell 182, 73\u201384 e16 (2020).","journal-title":"Cell"},{"key":"3630_CR69","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-82833-w","volume":"11","author":"G Valenzuela Nieto","year":"2021","unstructured":"Valenzuela Nieto, G. et al. Potent neutralization of clinical isolates of SARS-CoV-2 D614 and G614 variants by a monomeric, sub-nanomolar affinity nanobody. Sci. Rep. 11, 3318 (2021).","journal-title":"Sci. Rep."},{"key":"3630_CR70","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1126\/science.3285471","volume":"240","author":"M Better","year":"1988","unstructured":"Better, M., Chang, C. P., Robinson, R. R. & Horwitz, A. H. Escherichia coli secretion of an active chimeric antibody fragment. Science 240, 1041\u20131043 (1988).","journal-title":"Science"},{"key":"3630_CR71","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1002\/jgm.677","volume":"7","author":"L Zhang","year":"2005","unstructured":"Zhang, L., Leng, Q. & Mixson, A. J. Alteration in the IL-2 signal peptide affects secretion of proteins in vitro and in vivo. J. Gene Med. 7, 354\u2013365 (2005).","journal-title":"J. Gene Med."},{"key":"3630_CR72","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1126\/science.1243283","volume":"342","author":"JS McLellan","year":"2013","unstructured":"McLellan, J. S. et al. Structure-based design of a fusion glycoprotein vaccine for respiratory syncytial virus. Science 342, 592\u2013598 (2013).","journal-title":"Science"},{"key":"3630_CR73","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1016\/j.jmb.2009.07.057","volume":"392","author":"SP Boudko","year":"2009","unstructured":"Boudko, S. P. et al. Crystal structure of human collagen XVIII trimerization domain: a novel collagen trimerization Fold. J. Mol. Biol. 392, 787\u2013802 (2009).","journal-title":"J. Mol. Biol."},{"key":"3630_CR74","doi-asserted-by":"publisher","first-page":"8875","DOI":"10.1128\/JVI.76.17.8875-8889.2002","volume":"76","author":"RW Sanders","year":"2002","unstructured":"Sanders, R. W. et al. Stabilization of the soluble, cleaved, trimeric form of the envelope glycoprotein complex of human immunodeficiency virus type 1. J. Virol. 76, 8875\u20138889 (2002).","journal-title":"J. Virol."},{"key":"3630_CR75","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1016\/j.cell.2021.01.050","volume":"184","author":"A Sokal","year":"2021","unstructured":"Sokal, A. et al. Maturation and persistence of the anti-SARS-CoV-2 memory B cell response. Cell 184, 1201\u20131213 e1214 (2021).","journal-title":"Cell"},{"key":"3630_CR76","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-43575-y","volume":"9","author":"H Yamazaki","year":"2019","unstructured":"Yamazaki, H. et al. Endogenous APOBEC3B overexpression constitutively generates DNA substitutions and deletions in myeloma cells. Sci. Rep. 9, 7122 (2019).","journal-title":"Sci. Rep."},{"key":"3630_CR77","first-page":"3","volume":"17","author":"M Martin","year":"2011","unstructured":"Martin, M. Cutadapt removes adapter sequences from high-throughput sequencing reads. 2011 17, 3 (2011).","journal-title":"2011"},{"key":"3630_CR78","doi-asserted-by":"publisher","first-page":"2114","DOI":"10.1093\/bioinformatics\/btu170","volume":"30","author":"AM Bolger","year":"2014","unstructured":"Bolger, A. M., Lohse, M. & Usadel, B. Trimmomatic: a flexible trimmer for Illumina sequence data. Bioinformatics 30, 2114\u20132120 (2014).","journal-title":"Bioinformatics"},{"key":"3630_CR79","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2174\/1875036201307010001","volume":"7","author":"E Aronesty","year":"2013","unstructured":"Aronesty, E. Comparison of Sequencing Utility Programs. Open Bioinforma. J. 7, 1\u20138 (2013).","journal-title":"Open Bioinforma. J."},{"key":"3630_CR80","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/S0168-9525(00)02024-2","volume":"16","author":"P Rice","year":"2000","unstructured":"Rice, P., Longden, I. & Bleasby, A. EMBOSS: the European molecular biology open software suite. Trends Genet. 16, 276\u2013277 (2000).","journal-title":"Trends Genet."},{"key":"3630_CR81","doi-asserted-by":"publisher","first-page":"e0163962","DOI":"10.1371\/journal.pone.0163962","volume":"11","author":"W Shen","year":"2016","unstructured":"Shen, W., Le, S., Li, Y. & Hu, F. SeqKit: a cross-platform and ultrafast toolkit for FASTA\/Q file manipulation. PLoS ONE 11, e0163962 (2016).","journal-title":"PLoS ONE"},{"key":"3630_CR82","doi-asserted-by":"publisher","first-page":"2460","DOI":"10.1093\/bioinformatics\/btq461","volume":"26","author":"RC Edgar","year":"2010","unstructured":"Edgar, R. C. Search and clustering orders of magnitude faster than BLAST. Bioinformatics 26, 2460\u20132461 (2010).","journal-title":"Bioinformatics"},{"key":"3630_CR83","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1126\/science.abe4747","volume":"370","author":"Y Xiang","year":"2020","unstructured":"Xiang, Y. et al. Versatile and multivalent nanobodies efficiently neutralize SARS-CoV-2. Science 370, 1479\u20131484 (2020).","journal-title":"Science"},{"key":"3630_CR84","doi-asserted-by":"publisher","first-page":"e73027","DOI":"10.7554\/eLife.73027","volume":"10","author":"FD Mast","year":"2021","unstructured":"Mast, F. D. et al. Highly synergistic combinations of nanobodies that target SARS-CoV-2 and are resistant to escape. Elife 10, e73027 (2021).","journal-title":"Elife"},{"key":"3630_CR85","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-79036-0","volume":"10","author":"TJ Esparza","year":"2020","unstructured":"Esparza, T. J., Martin, N. P., Anderson, G. P., Goldman, E. R. & Brody, D. L. High affinity nanobodies block SARS-CoV-2 spike receptor binding domain interaction with human angiotensin converting enzyme. Sci. Rep. 10, 22370 (2020).","journal-title":"Sci. Rep."},{"key":"3630_CR86","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1038\/s41586-022-04462-1","volume":"603","author":"R Suzuki","year":"2022","unstructured":"Suzuki, R. et al. Attenuated fusogenicity and pathogenicity of SARS-CoV-2 Omicron variant. Nature 603, 700\u2013705 (2022).","journal-title":"Nature"},{"key":"3630_CR87","doi-asserted-by":"publisher","first-page":"4124","DOI":"10.1158\/0008-5472.CAN-20-4245","volume":"81","author":"Y Konishi","year":"2021","unstructured":"Konishi, Y. et al. Intravital imaging identifies the VEGF-TXA2 axis as a critical promoter of PGE2 secretion from tumor cells and immune evasion. Cancer Res. 81, 4124\u20134132 (2021).","journal-title":"Cancer Res."},{"key":"3630_CR88","doi-asserted-by":"publisher","first-page":"e1004552","DOI":"10.1371\/journal.ppat.1004552","volume":"10","author":"LE McCoy","year":"2014","unstructured":"McCoy, L. E. et al. Molecular evolution of broadly neutralizing Llama antibodies to the CD4-binding site of HIV-1. PLoS Pathog. 10, e1004552 (2014).","journal-title":"PLoS Pathog."},{"key":"3630_CR89","doi-asserted-by":"publisher","unstructured":"Fujita, J. et al. Epoxidized graphene grid for high-throughput high-resolution cryoEM structural analysis. bioRxiv https:\/\/doi.org\/10.1101\/2021.11.17.468963 (2021).","DOI":"10.1101\/2021.11.17.468963"},{"key":"3630_CR90","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-24715-3","volume":"12","author":"T Yamaguchi","year":"2021","unstructured":"Yamaguchi, T. et al. Structure of the molecular bushing of the bacterial flagellar motor. Nat. Commun. 12, 4469 (2021).","journal-title":"Nat. Commun."},{"key":"3630_CR91","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1107\/S2052252520000081","volume":"7","author":"J Zivanov","year":"2020","unstructured":"Zivanov, J., Nakane, T. & Scheres, S. H. W. Estimation of high-order aberrations and anisotropic magnification from cryo-EM data sets in RELION-3.1. IUCrJ 7, 253\u2013267 (2020).","journal-title":"IUCrJ"},{"key":"3630_CR92","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1038\/nmeth.4193","volume":"14","author":"SQ Zheng","year":"2017","unstructured":"Zheng, S. Q. et al. MotionCor2: anisotropic correction of beam-induced motion for improved cryo-electron microscopy. Nat. Methods 14, 331\u2013332 (2017).","journal-title":"Nat. Methods"},{"key":"3630_CR93","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.jsb.2015.08.008","volume":"192","author":"A Rohou","year":"2015","unstructured":"Rohou, A. & Grigorieff, N. CTFFIND4: fast and accurate defocus estimation from electron micrographs. J. Struct. Biol. 192, 216\u2013221 (2015).","journal-title":"J. Struct. Biol."},{"key":"3630_CR94","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1038\/s41592-020-00990-8","volume":"17","author":"A Punjani","year":"2020","unstructured":"Punjani, A., Zhang, H. & Fleet, D. J. Non-uniform refinement: adaptive regularization improves single-particle cryo-EM reconstruction. Nat. Methods 17, 1214\u20131221 (2020).","journal-title":"Nat. Methods"},{"key":"3630_CR95","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1126\/science.abf2303","volume":"372","author":"J Zhang","year":"2021","unstructured":"Zhang, J. et al. Structural impact on SARS-CoV-2 spike protein by D614G substitution. Science 372, 525\u2013530 (2021).","journal-title":"Science"},{"key":"3630_CR96","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1002\/jcc.20084","volume":"25","author":"EF Pettersen","year":"2004","unstructured":"Pettersen, E. F. et al. UCSF Chimera\u2014a visualization system for exploratory research and analysis. J. Comput. Chem. 25, 1605\u20131612 (2004).","journal-title":"J. Comput. Chem."},{"key":"3630_CR97","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1107\/S0907444910007493","volume":"66","author":"P Emsley","year":"2010","unstructured":"Emsley, P., Lohkamp, B., Scott, W. G. & Cowtan, K. Features and development of Coot. Acta Crystallogr D. Biol. Crystallogr 66, 486\u2013501 (2010).","journal-title":"Acta Crystallogr D. Biol. Crystallogr"},{"key":"3630_CR98","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1107\/S0907444909052925","volume":"66","author":"PD Adams","year":"2010","unstructured":"Adams, P. D. et al. PHENIX: a comprehensive Python-based system for macromolecular structure solution. Acta Crystallogr D. Biol. Crystallogr 66, 213\u2013221 (2010).","journal-title":"Acta Crystallogr D. Biol. Crystallogr"},{"key":"3630_CR99","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1107\/S0907444909042073","volume":"66","author":"VB Chen","year":"2010","unstructured":"Chen, V. B. et al. MolProbity: all-atom structure validation for macromolecular crystallography. Acta Crystallogr D. Biol. Crystallogr 66, 12\u201321 (2010).","journal-title":"Acta Crystallogr D. Biol. Crystallogr"},{"key":"3630_CR100","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1002\/pro.3943","volume":"30","author":"EF Pettersen","year":"2021","unstructured":"Pettersen, E. F. et al. UCSF ChimeraX: structure visualization for researchers, educators, and developers. Protein Sci. 30, 70\u201382 (2021).","journal-title":"Protein Sci."},{"key":"3630_CR101","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1107\/S0907444909047337","volume":"66","author":"W Kabsch","year":"2010","unstructured":"Kabsch, W. Xds. Acta Crystallogr D. Biol. Crystallogr 66, 125\u2013132 (2010).","journal-title":"Acta Crystallogr D. Biol. Crystallogr"},{"key":"3630_CR102","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1107\/S0907444913000061","volume":"69","author":"PR Evans","year":"2013","unstructured":"Evans, P. R. & Murshudov, G. N. How good are my data and what is the resolution. Acta Crystallogr D. Biol. Crystallogr 69, 1204\u20131214 (2013).","journal-title":"Acta Crystallogr D. Biol. Crystallogr"},{"key":"3630_CR103","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1107\/S0907444909042589","volume":"66","author":"A Vagin","year":"2010","unstructured":"Vagin, A. & Teplyakov, A. Molecular replacement with MOLREP. Acta Crystallogr D. Biol. Crystallogr 66, 22\u201325 (2010).","journal-title":"Acta Crystallogr D. Biol. Crystallogr"},{"key":"3630_CR104","doi-asserted-by":"publisher","DOI":"10.1038\/srep19211","volume":"6","author":"MB Braun","year":"2016","unstructured":"Braun, M. B. et al. Peptides in headlock\u2014a novel high-affinity and versatile peptide-binding nanobody for proteomics and microscopy. Sci. Rep. 6, 19211 (2016).","journal-title":"Sci. Rep."},{"key":"3630_CR105","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1107\/S0907444911001314","volume":"67","author":"GN Murshudov","year":"2011","unstructured":"Murshudov, G. N. et al. REFMAC5 for the refinement of macromolecular crystal structures. Acta Crystallogr D. Biol. Crystallogr 67, 355\u2013367 (2011).","journal-title":"Acta Crystallogr D. Biol. Crystallogr"},{"key":"3630_CR106","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1107\/S0907444910045749","volume":"67","author":"MD Winn","year":"2011","unstructured":"Winn, M. D. et al. Overview of the CCP4 suite and current developments. Acta Crystallogr D. Biol. Crystallogr 67, 235\u2013242 (2011).","journal-title":"Acta Crystallogr D. Biol. Crystallogr"},{"key":"3630_CR107","doi-asserted-by":"publisher","first-page":"7001","DOI":"10.1073\/pnas.2002589117","volume":"117","author":"S Matsuyama","year":"2020","unstructured":"Matsuyama, S. et al. Enhanced isolation of SARS-CoV-2 by TMPRSS2-expressing cells. Proc. Natl Acad. Sci. USA 117, 7001\u20137003 (2020).","journal-title":"Proc. Natl Acad. Sci. USA"}],"container-title":["Communications Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s42003-022-03630-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42003-022-03630-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42003-022-03630-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,25]],"date-time":"2022-11-25T03:57:29Z","timestamp":1669348649000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s42003-022-03630-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,6]]},"references-count":107,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["3630"],"URL":"https:\/\/doi.org\/10.1038\/s42003-022-03630-3","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2021.10.25.465714","asserted-by":"object"}]},"ISSN":["2399-3642"],"issn-type":[{"value":"2399-3642","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,6]]},"assertion":[{"value":"10 November 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 June 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 July 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Kyoto University, Osaka University, and COGNANO Inc. have filed a patent application (JP2021-170471) in connection with this research, on which R.M., J.F., A.T.-K., Ko.S., K.K., H.Y., A.I., F.M., Ke.N., K.Y., T.I., I.A., Y.M., Haruyasu Asahara and Maiko Moriguchi are inventors. A.I. is a stockholder of COGNANO Inc., which has patents and ownership of antibody sequences (JP2021-089414) and an in-house method of identifying antibodies (PCT\/JP2019\/021353) described in this study on which A.I. is an inventor. R.M., H.Y., and K.K. are employees of COGNANO Inc. The other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"669"}}